What is the relative efficacy of hexylresorcinol lozenges compared with chloraseptic (phenol) spray, lidocaine lozenges, acetaminophen (Tylenol), and ibuprofen for treating sore throat pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ibuprofen is the most effective option for sore throat pain relief

For treating sore throat pain, ibuprofen (400 mg) provides superior efficacy compared to acetaminophen (Tylenol), with both being more effective than topical agents like chloraseptic (phenol), lidocaine lozenges, or hexylresorcinol lozenges.

Evidence-Based Treatment Hierarchy

First-Line: NSAIDs (Ibuprofen)

The IDSA guidelines 1 provide a strong recommendation with high-quality evidence that NSAIDs such as ibuprofen are superior for moderate to severe sore throat symptoms. Multiple randomized, double-blind, placebo-controlled studies demonstrate that ibuprofen provides better pain relief than acetaminophen, with this superiority becoming apparent after 2 hours and persisting throughout treatment 1.

A head-to-head comparison study found that ibuprofen 400 mg was significantly more effective than acetaminophen 1000 mg on all rating scales at all time points after 2 hours (p < 0.01) 2. The European guideline 3 confirms that ibuprofen and diclofenac are slightly more effective than paracetamol for pain relief, with ibuprofen being the safest option.

Second-Line: Acetaminophen (Tylenol)

Acetaminophen provides significant pain relief compared to placebo 1, though improvement in symptoms is not always equivalent to that obtained with ibuprofen. It remains a reasonable alternative when NSAIDs are contraindicated.

Topical Agents: Limited Role

The guidelines explicitly state that topical agents including lidocaine, benzocaine, and other anesthetics may give only temporary symptomatic relief 1. While hexylresorcinol lozenges demonstrated superiority over placebo in one study 4, with rapid onset from 1-5 minutes, the overall effect is modest compared to systemic analgesics.

Chloraseptic (phenol) spray is not specifically addressed in the high-quality evidence, suggesting limited data supporting its efficacy compared to established treatments.

Practical Treatment Algorithm

  1. Start with ibuprofen 400 mg for adults with moderate to severe sore throat pain

    • Provides superior pain relief starting at 2 hours
    • Well-tolerated with no significant adverse events in pharyngitis studies 1
    • Continue as needed for symptom control
  2. Use acetaminophen 1000 mg if NSAIDs are contraindicated

    • Effective but less potent than ibuprofen
    • Safer in patients with GI concerns or bleeding risk
  3. Consider topical agents as adjuncts only, not primary therapy

    • May provide rapid but temporary relief (1-15 minutes)
    • Lozenges pose choking hazard in young children 1
    • Do not replace systemic analgesics

Critical Caveats

  • Avoid aspirin in children due to Reye syndrome risk (strong recommendation) 1
  • Topical anesthetics provide temporary relief only—patients need systemic analgesics for sustained pain control
  • The modest additional benefit of lozenges over non-medicated lozenges may not justify their use as monotherapy 5
  • Recent evidence shows combining ibuprofen with AMC/DCBA lozenges provides faster initial relief (0-30 minutes vs 0-60 minutes) but no difference in overall efficacy 6

Bottom Line

Ibuprofen 400 mg is the evidence-based first choice for sore throat pain, providing superior and sustained relief compared to all other options mentioned. Acetaminophen is an acceptable but less effective alternative. Topical agents like chloraseptic, lidocaine, or hexylresorcinol lozenges offer only modest, temporary benefit and should not replace systemic analgesics as primary therapy.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.